Mitochondrial Reactive Oxygen Species Participate in Signaling Triggered by Heme in Macrophages and upon Hemolysis

Area of Science:

• Immunology
• Cellular Biology
• Pathophysiology

Background:

• Hemolysis releases heme, causing oxidative stress and inflammation.
• Macrophages play a central role in heme-induced inflammatory responses.
• Heme acts as a damage-associated molecular pattern, activating inflammatory pathways.

Purpose of the Study:

• To elucidate the role of reactive oxygen species (ROS) in heme-induced inflammatory signaling and cytokine production in macrophages.
• To investigate the signaling pathways activated by heme in macrophages, including MAPK phosphorylation and cytokine expression.
• To determine the contribution of TLR4, TNFR1, and mitochondrial ROS to heme-induced lethality in vivo.

Main Methods:

• Primary mouse macrophages were treated with heme.
• Analysis of signaling pathways including MAPK phosphorylation, ROS generation, and cytokine production.
• Inhibition of ROS generation using N-acetyl-l-cysteine and spleen tyrosine kinase (Syk) inhibition.
• Assessment of heme-induced lethality in mice.

Main Results:

• Heme activates multiple signaling pathways, leading to MAPK phosphorylation and cytokine expression in macrophages.
• The TLR4/MyD88 pathway is crucial for p38 phosphorylation and cytokine secretion.
• ROS generation and Syk activation are critical for most heme-induced inflammatory signaling.
• Mitochondrial ROS, dependent on Syk, specifically promote ERK1/2 phosphorylation and CXCL1/TNF production.
• Lethality in sterile hemolysis models requires TLR4, TNFR1, and mitochondrial ROS.

Conclusions:

• Heme-induced inflammation involves complex signaling crosstalk between TLR4, ROS, and Syk pathways.
• Targeting TLR4, TNFR1, and mitochondrial ROS may offer therapeutic strategies for hemolytic disorders.
• Understanding these pathways is crucial for mitigating tissue damage in conditions involving hemolysis.